Neutropenia

G-CSF May Only Modestly Prevent Neutropenia-related Hospitalization

G-CSF May Only Modestly Prevent Neutropenia-related Hospitalization

By

Primary prophylaxis with granulocyte colony-stimulating factor provided only a low-to-modest benefit in reducing neutropenia-related hospitalization in patients with breast cancer receiving low-to-intermediate risk chemotherapy regimens.

Early Discontinuation of Pegfilgrastim May Increase Risk of Febrile Neutropenia

Early Discontinuation of Pegfilgrastim May Increase Risk of Febrile Neutropenia

By

The risk of second-cycle febrile neutropenia was significantly higher among patients who discontinued pegfilgrastim after the first cycle.

Zarxio Efficient, Well Tolerated in Patients With Cancer in Routine Practice

Zarxio Efficient, Well Tolerated in Patients With Cancer in Routine Practice

By

Zarxio (filgrastim-sndz), a biosimilar of filgrastim, is efficient and well tolerated for the prophylaxis of chemotherapy-induced neutropenia.

Pegteograstim may be effective for reducing chemotherapy-induced neutropenia

Pegteograstim may be effective for reducing chemotherapy-induced neutropenia

Pegteograstim is as effective as pegfilgrastim in reducing chemotherapy-induced neutropenia in patients with breast cancer.

Efficacy, safety of biosimilar filgrastim similar to that of filgrastim in daily practice

Efficacy, safety of biosimilar filgrastim similar to that of filgrastim in daily practice

Effectiveness and safety of biosimilar filgrastim (Zarxio) in daily clinical practice are similar to that of the originator filgrastim.

In breast cancer, febrile neutropenia-related admissions account for significant mortality

In breast cancer, febrile neutropenia-related admissions account for significant mortality

Febrile neutropenia-related hospitalizations still account for morbidity, and mortality among patients with breast cancer.

Study Recommends Use of Professional Temporal Thermometer in Adults

By

Research supports use of the Exergen professional TAT-5000 temporal thermometer as a noninvasive alternative to measure temperature in adult patients to detect febrile neutropenia, found research presented at the ONS 38th Annual Congress.

ASCO issues guideline for febrile neutropenia in adults

ASCO issues guideline for febrile neutropenia in adults

Panel addresses prophylaxis and management of fever and neutropenia in cancer outpatients.

CDC focuses on infection prevention

CDC focuses on infection prevention

A new initiative launched by CDC is designed to reduce the risk of life-threatening infection in cancer patients undergoing chemotherapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs